GB201213087D0 - Inhibition of HIV-1 infection - Google Patents
Inhibition of HIV-1 infectionInfo
- Publication number
- GB201213087D0 GB201213087D0 GB201213087A GB201213087A GB201213087D0 GB 201213087 D0 GB201213087 D0 GB 201213087D0 GB 201213087 A GB201213087 A GB 201213087A GB 201213087 A GB201213087 A GB 201213087A GB 201213087 D0 GB201213087 D0 GB 201213087D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- hiv
- infection
- inhibition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 208000031886 HIV Infections Diseases 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201213087A GB201213087D0 (en) | 2012-07-24 | 2012-07-24 | Inhibition of HIV-1 infection |
| PCT/EP2013/065665 WO2014016358A1 (en) | 2012-07-24 | 2013-07-24 | Inhibition of hiv-1 infection by inhibition of binding of cpsf to viral capsid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201213087A GB201213087D0 (en) | 2012-07-24 | 2012-07-24 | Inhibition of HIV-1 infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201213087D0 true GB201213087D0 (en) | 2012-09-05 |
Family
ID=46881833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB201213087A Ceased GB201213087D0 (en) | 2012-07-24 | 2012-07-24 | Inhibition of HIV-1 infection |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201213087D0 (en) |
| WO (1) | WO2014016358A1 (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2840095A1 (en) | 2011-07-06 | 2013-01-10 | Gilead Sciences, Inc. | Compounds for the treatment of hiv |
| US9012441B2 (en) | 2013-01-09 | 2015-04-21 | Gilead Sciences, Inc. | Therapeutic compounds |
| TW201443037A (en) | 2013-01-09 | 2014-11-16 | Gilead Sciences Inc | Therapeutic compounds |
| NZ631762A (en) | 2013-01-09 | 2017-02-24 | Gilead Sciences Inc | 5-membered heteroaryls and their use as antiviral agents |
| TWI694071B (en) | 2013-03-01 | 2020-05-21 | 美商基利科學股份有限公司 | Therapeutic compounds for the treatment of retroviridae virus infections |
| US10202353B2 (en) | 2014-02-28 | 2019-02-12 | Gilead Sciences, Inc. | Therapeutic compounds |
| GB201608874D0 (en) * | 2016-05-20 | 2016-07-06 | Medical Res Council And Ucl Business Plc | Novel crystal structure and use thereof |
| HUE063811T2 (en) | 2016-08-19 | 2024-02-28 | Gilead Sciences Inc | Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection |
| AR112412A1 (en) | 2017-08-17 | 2019-10-23 | Gilead Sciences Inc | CHOLINE SALT FORMS OF AN HIV CAPSID INHIBITOR |
| AR112413A1 (en) | 2017-08-17 | 2019-10-23 | Gilead Sciences Inc | SOLID FORMS OF AN HIV CAPSID INHIBITOR |
| WO2019161017A1 (en) | 2018-02-15 | 2019-08-22 | Gilead Sciences, Inc. | Pyridine derivatives and their use for treating hiv infection |
| CA3175384A1 (en) | 2018-02-16 | 2019-08-22 | Gilead Sciences, Inc. | Methods and intermediates for preparing therapeutic compounds useful in the treatment of retroviridae viral infection |
| TWI814350B (en) | 2018-07-16 | 2023-09-01 | 美商基利科學股份有限公司 | Capsid inhibitors for the treatment of hiv |
| CN109897088B (en) * | 2019-03-19 | 2022-06-17 | 山东大学 | Phenylalanine derivative containing N- (2-oxoethyl) benzene sulfonamide and preparation method and application thereof |
| WO2020247933A2 (en) * | 2019-06-07 | 2020-12-10 | The Curators Of The University Of Missouri | Peptide inhibitors for the inhibition of hiv capsid |
| WO2021108544A1 (en) | 2019-11-26 | 2021-06-03 | Gilead Sciences, Inc. | Capsid inhibitors for the prevention of hiv |
| TWI858267B (en) | 2020-06-25 | 2024-10-11 | 美商基利科學股份有限公司 | Capsid inhibitors for the treatment of hiv |
| TW202342447A (en) | 2021-12-03 | 2023-11-01 | 美商基利科學股份有限公司 | Therapeutic compounds for hiv virus infection |
| JP7765637B2 (en) | 2021-12-03 | 2025-11-06 | ギリアード サイエンシーズ, インコーポレイテッド | Therapeutic compounds for HIV virus infections |
| TW202412779A (en) | 2021-12-03 | 2024-04-01 | 美商基利科學股份有限公司 | Therapeutic compounds for hiv virus infection |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102464654B (en) * | 2010-11-12 | 2016-01-13 | 上海泓博智源医药技术有限公司 | Antiviral compound |
-
2012
- 2012-07-24 GB GB201213087A patent/GB201213087D0/en not_active Ceased
-
2013
- 2013-07-24 WO PCT/EP2013/065665 patent/WO2014016358A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014016358A1 (en) | 2014-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201213087D0 (en) | Inhibition of HIV-1 infection | |
| IL287057A (en) | Purification of iduronate-2 sulfatase | |
| ZA201501847B (en) | Formulations of enzalutamide | |
| GB2520221B (en) | Stacking of gloves | |
| ZA201405820B (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
| IL237154A (en) | Inhibitors of human immunodeficiency virus replication | |
| PT2814490T (en) | Inhibitors of human immunodeficiency virus replication | |
| SG11201405057YA (en) | Treatment of biomass | |
| GB201217097D0 (en) | Treatment of bacterial infection | |
| ZA201406082B (en) | Use of ccr3-inhibitors | |
| EP2858975A4 (en) | INHIBITORS OF FBXO-3 | |
| GB201501016D0 (en) | Preparation of 18F-fluciclovine | |
| GB201309274D0 (en) | Treatment Of Fuel | |
| PL2888228T3 (en) | Inhibitors of cd40-traf6 interaction | |
| EP2712317A4 (en) | Prevention of infection | |
| GB201207907D0 (en) | Treatment of depression | |
| FR2997080B1 (en) | INHIBITORS OF NEPRILYSINE | |
| GB201012168D0 (en) | Treatment of viral infections | |
| GB201207431D0 (en) | Intravaginal treatment of gynacological conditions | |
| IL233879A0 (en) | Drypowder formulations of dnase i | |
| GB201203101D0 (en) | Preparations of antibacterial bisbenzimidazoles | |
| AU2012900670A0 (en) | Treatment of seborrhoea | |
| GB201212715D0 (en) | Treatment of fungal infections | |
| IL233740A0 (en) | Treatment of liver conditions | |
| GB201001821D0 (en) | Treatment of viral infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |